Search
-
Reset or Retreat? The Ipsos ESG Council Report 2025
The global landscape of Environmental, Social, and Governance (ESG) is in flux, presenting both unprecedented challenges and exciting opportunities for businesses.
-
Improving access to healthcare by removing transportation barriers
Read how understanding the gaps and issues people face can give transportation planners, policymakers, and healthcare providers the data they need to tackle these problems in their communities.
-
Customer Perspective: An Ipsos Podcast
An Ipsos podcast series exploring best practices in customer experience strategies, mystery shopping and channel performance.
-
Change Means Friction
By understanding and leveraging cognitive conflict, businesses and policymakers can develop more effective strategies for driving positive change in consumer behavior, social attitudes, and more.
-
Money Talks or Budget Walks
Need proof that CX drives financial/operational gains at all levels of the organization? Read our latest paper outlining tips for delivering a return on CX investment.
-
Here’s Why These Cities are America’s Top 100 of 2024
The Ipsos / Resonance Consultancy America’s Best Cities research now includes perception data as a factor. Access the report here.
-
How electric vehicle incentives can charge the market
What policymakers need to know about public opinion to create an equitable and accessible EV market across the country and in key states.
-
Why panel-member first is good for research and business
The KnowledgePanel employs a highly effective approach to online probability research that emphasizes the experience and life cycle of panel members, something we call the Panel-Member First Approach.
-
What Regulators Need to Know About Third-Party App Installers
If regulators want to create a competitive app installer market, consumers must be able to have a fast, easy download experience, while still feeling safe.
-
The Patient Perspective: Evaluating Time and Treatment While Living with Metastatic Breast Cancer
The results of this research demonstrate the time-burden on ER+, HER2- mBC patients and their loved ones when going to receive care and the potential difficulty of care when an IM injection is part of their treatment plan.